Price data may be delayed — our pipeline hasn't confirmed a fresh update recently. Figures shown could be from an earlier session.
ScreenerHero
DVADaVita Inc.
NYSE · US · Healthcare · Medical Care Facilities · davita.com
175.00USD-1.28%Mkt Cap: 11.38B $P/E: 15.02

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
FME
Fresenius Medical Care AG
$11.72BUSDP/E 12.1
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
EMEIS
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5
ADUS
Addus HomeCare Corporation
$2.24BUSDP/E 21.0

Key Statistics

Company
Market Cap11.38B $
Enterprise Value25.74B $
Revenue (TTM)14.01B $
Gross Profit4.40B $
Net Income (TTM)746.80M $
Revenue/Share204.69 USD
Last Price175.00 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees78.0K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)15.02
P/E (Forward)10.30
PEG0.55
EV/EBITDA9.11
EV/Revenue1.84
P/S0.80
P/B-14.65
EPS (TTM)11.67
EPS (Forward)17.02
52W Range
101.0051% of range247.49
52W High247.49 USD
52W Low101.00 USD
Profitability
Gross Margin32.25%
Oper. Margin16.06%
EBITDA Margin20.17%
Profit Margin5.47%
ROE-114.70%
ROA4.27%
Growth
Revenue Growth5.20%
Earnings Growth55.80%
Cash Flow & Leverage
Operating CF1.89B $
CapEx (TTM)575.86M $
FCF Margin7.44%
FCF Yield9.16%
Net Debt12.72B $
Net Debt/EBITDA4.50
Balance Sheet
Debt/Equity-19.77
Current Ratio1.47
Quick Ratio1.33
Book Value/Sh-11.9630 USD
Cash/Share10.80 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateSep 9, 2013
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)218.43 USD
Upside (mean)+24.8%
Target Range165.00 USD – 270.00 USD
$165.00+24.8% to mean$270.00
# Analysts7
Ownership
Shares Out.64.19M
Float33.94M
Insiders46.91%
Institutions49.33%
Short Interest
Short Ratio6.3d
Short % Float13.20%
Short % Out.6.72%
Shares Short4.28M
Short (prev mo.)4.54M
Technical
SMA 50214.89 (-18.6%)
SMA 200160.92 (+8.7%)
Beta0.87
S&P 52W Chg18.16%
Avg Vol (30d)757.88K
Avg Vol (10d)739.36K
Technical Indicators
RSI (14)25.4
MACD-13.3536
MACD Signal-9.2231
MACD Hist.-4.1306
BB Upper265.30 USD
BB Middle208.45 USD
BB Lower151.60 USD
BB Width54.55%
ATR (14)7.416 USD
Vol Ratio (20d)0.31x